logo

IDXX

IDEXX Laboratories·NASDAQ
--
--(--)
--
--(--)
8.79 / 10
Outperform

The company's fundamental score of 8.8/10 is driven by top-quartile metrics: Profit-MV (0.1468, group 1), Net income-Revenue (0.6519, group 2), Cash-MV (-0.9764, group 1), ROE (%) (66.2021, group 4), and others. Historical back-tests show positive one-month returns for most factors (e.g., 3.80% for Profit-MV, 1.92% for ROE%), indicating resilience. Weaknesses lie in Asset-MV and Revenue-MV, both in group 1 with negative historical returns (-3.79%, -0.34%), but these carry lower weights in the composite score. The fundamental structure is therefore solid with clear growth and profitability drivers, supporting an Outperform stance.

Fundamental(8.79)SentimentTechnical

Analysis Checks(8/10)

Revenue-MV
Value-1.37
Score1/3
Weight-1.49%
1M Return-0.34%
Annualized return on equity (%)
Value66.20
Score3/3
Weight10.67%
1M Return1.92%
Net cash flow from operating activities / Operating revenue (%)
Value27.46
Score3/3
Weight10.93%
1M Return1.92%
Profit-MV
Value0.15
Score3/3
Weight21.55%
1M Return3.80%
Net income-Revenue
Value0.65
Score2/3
Weight22.15%
1M Return3.71%
ROE (diluted) (%)
Value65.99
Score3/3
Weight10.36%
1M Return1.88%
Asset-MV
Value-0.53
Score0/3
Weight-16.60%
1M Return-3.79%
ROE (%)
Value66.20
Score3/3
Weight10.67%
1M Return1.92%
Cash-MV
Value-0.98
Score3/3
Weight21.86%
1M Return3.66%
Net profit / Total profit (%)
Value80.01
Score3/3
Weight9.89%
1M Return1.83%
Is IDXX undervalued or overvalued?
  • IDXX scores 8.79/10 on fundamentals and holds a Discounted valuation at present. Backed by its 66.20% ROE, 24.62% net margin, 48.68 P/E ratio, 32.12 P/B ratio, and 22.28% earnings growth, these metrics solidify its Outperform investment rating.